AbbVie bets on Alzheimer’s immunotherapy with big biotech deal – Reuters
|
AbbVie bets on Alzheimer's immunotherapy with big biotech deal
Reuters The idea of using immunotherapy in Alzheimer's mirrors the success of immuno-oncology in cancer, where drugs that help the immune system battle tumors are revolutionizing care. Scientists at AbbVie and Alector believe there is growing evidence that … |
